Warning Issued to Doctors In Regard to SynchroMed Infusion Pumps

Posted on

Medtronic and the Food and Drug Administration are warning of potential complications that could result when an administrator fails to use the proper drugs in conjunction with the SynchroMed EL and the SynchroMed II Implantable Drug Infusion Pump.  These systems, which distribute drugs to a specified portion of a patient’s body, are only to be used with six distinct drugs.  If other medications are used, performance can be hindered, the pump motor can fail partially or completely, and drug distribution can thus be brought to a halt.  Serious complications could then arise.  Doctors should only use drugs specified by the labels of the devices to prevent such an occurrence.

Click here to learn more about the warning.